Cargando…
Clinical spectrum and management options in Vogt–Koyanagi–Harada disease
PURPOSE: The aim of this study was to describe the clinical features, treatment options, and visual outcome of Vogt–Koyanagi–Harada (VKH) disease patients over a 9-year period. METHOD: A retrospective chart analysis of 32 patients with VKH, from January 2007 to December 2015, at a tertiary care gove...
Autores principales: | Lodhi, Sikander AK, Reddy, JM Lokabhi, Peram, Venkataratnam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557111/ https://www.ncbi.nlm.nih.gov/pubmed/28848322 http://dx.doi.org/10.2147/OPTH.S134977 |
Ejemplares similares
-
Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease
por: Moreker, Mayur R, et al.
Publicado: (2007) -
Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020) -
Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020) -
Vogt-Koyanagi-Harada Disease and COVID
por: Manni, Priscilla, et al.
Publicado: (2023) -
An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021)